Healthline
February 17, 2025
Share on PinterestLaws that target the mental and physical health of transgender Americans may cause significant harm. ROBYN BECK/AFP via Getty Images Federal judges have struck […]
February 15, 2025
Share on PinterestSuper Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis, an autoimmune skin condition. Brooke Sutton/Getty Images Super […]
February 15, 2025
Share on PinterestNSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). Josh Brasted/Getty Images NSYNC’s Lance […]
February 14, 2025
Share on PinterestFor the first time, the death rate for the flu is higher than the mortality rate for COVID-19. Daniel de la Hoz/Getty Images The […]
Medscape
April 16, 2025
TOPLINE: Patients with carotid tandem lesions who received intravenous thrombolysis before endovascular treatment showed similar functional outcomes and haemorrhage risks as those who received endovascular treatment […]
April 16, 2025
Pre-exposure prophylaxis (PrEP) for HIV is a highly effective tool for preventing HIV transmission in all populations and countries. However, despite being approved and available by […]
April 16, 2025
TOPLINE: Preserved ratio impaired spirometry (PRISm) was associated with the development of airway obstruction over 10 years of follow-up, independent of smoking habits, with comparable odds […]
April 16, 2025
Patients undergoing kidney transplantation in regions with the highest heat indexes show increased rates of kidney function decline and major adverse kidney events (MAKEs) compared with […]
FDA
March 21, 2025
For Immediate Release: March 21, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, […]
March 21, 2025
Patient input can help inform the therapeutic context for regulatory review. Patient input also can inform the selection of clinical outcomes, ensure the appropriateness of instruments […]
March 21, 2025
FDA develops resources – workshops, webinars, and seminars – to help generic drug manufacturers improve the quality of their abbreviated new drug application (ANDA) submissions and […]
March 20, 2025
Action The U.S. Food and Drug Administration has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G) to reduce proteinuria. Fabhalta is […]
